Logout

Header
For Healthcare Professionals
Register now

Are you ready to start an educational journey?

Join our multidisciplinary academy for the care of patients with kidney or metabolic or heart conditions

Sign Up
Obese patient diagnosed with Heart Failure with preserved ejection fraction

Patient Cases

See all patient cases
Overweight patient diagnosed with T2D
PPT

Overweight patient diagnosed with T2D

Overweight patient diagnosed with T2D & COPD
PPT

Overweight patient diagnosed with T2D & COPD

Patient with peripheral artery disease at the risk of CV events
PPT

Patient with peripheral artery disease at the risk of CV events

Get Access

Are you aware ...?

CKD

850M

people live with CKD worldwide1

T2D

537M

people live with T2D worldwide2

HF

64M

people live with HF worldwide3

Disease Management across conditions

CKD, T2D and HF conditions are progressive in nature and are interrelated. The presence of either one of these conditions can amplify risk and accelerate progression across the other conditions.⁴⁻⁶ The ACROSS academy supports with foundational knowledge for diagnosing and the active management of patients with kidney or metabolic or heart diseases.

Disease Management across conditions

Podcast

See all

Podcast

Kidney disease in the context of T2D management

Published 23. September 2022Playtime - 00:14:42 min

Listen Here
Kidney disease in the context of T2D management

Steering Committee

Meet our Steering Committee!

Meet our Steering Committee! We are proud to work with a group of dedicated and experienced doctors that drive the development of our educational content.

Learn more
Steering Committee

References

  1. More than 850 million worldwide have some form of kidney disease: Help raise awareness. International Society of Nephrology. November 27, 2020. Accessed May 22, 2023. https://www.theisn.org/blog/2020/11/27/more-than-850-million-worldwide-have-some-form-of-kidney-disease-help-raise-awareness/.

  2. Magliano DJ, Boyko EJ; IDF Diabetes Atlas 10th edition scientific committee. IDF DIABETES ATLAS [Internet]. 10th edition. Brussels: International Diabetes Federation; 2021. Available from: https://www.ncbi.nlm.nih.gov/books/NBK581934/.

  3. Bragazzi NL, Zhong W, Shu J, Abu Much A, Lotan D, Grupper A, et al. Burden of heart failure and underlying causes in 195 countries and territories from 1990 to 2017. Eur J Prev Cardiol. 2021.

  4. Kalra S, Aydin H, Sahay M, et al. Cardiorenal syndrome in type 2 diabetes mellitus—rational use of sodium-glucose cotransporter-2 inhibitors. Eur Endocrinol. 2020;16(2):113-121.

  5. Leon BM, Maddox TM. Diabetes and cardiovascular disease: epidemiology, biological mechanisms, treatment recommendations and future research. World J Diabetes. 2015;6(13):1246-1258.

  6. Centers for Disease Control and Prevention. Chronic Kidney Disease (CKD) Surveillance System. Accessed December 9, 2022. https://nccd.cdc.gov/ckd/AreYouAware.aspx?emailDate=September_2019.